3rd Quarter - Report
MEHLMAN CONSULTING, INC. for VIZIENT INC
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Group purchasing organization issues. S. 2615, Increasing Competition in Pharmaceuticals Act. Prescription drug and inpatient drug costs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN ROSEN | — |
Medicare/Medicaid MMM
Group purchasing organization issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN ROSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.